32 results
DEF 14A
IMCR
Immunocore Holdings plc
12 Apr 24
Definitive proxy
4:20pm
to promote the creation of shareholder value over the long term, the board of directors recognizes that executive compensation disclosures are made … the long-term interests of our shareholders.
Shareholder Recommendations and Nominations
Our nominating and corporate governance committee considers
424B7
IMCR
Immunocore Holdings plc
5 Apr 24
Prospectus with selling stockholder info
4:34pm
) the likely consequences of any decision in the long-term, (ii) the interests of the company’s employees, (iii) the need to foster the company’s business
PRE 14A
IMCR
Immunocore Holdings plc
2 Apr 24
Preliminary proxy
4:45pm
program is designed to promote the creation of shareholder value over the long term, the board of directors recognizes that executive compensation … and is committed to represent the long-term interests of our shareholders.
Shareholder Recommendations and Nominations
Our nominating and corporate governance
S-3ASR
IMCR
Immunocore Holdings plc
20 Mar 24
Automatic shelf registration
8:51pm
) the likely consequences of any decision in the long-term, (ii) the interests of the company’s employees, (iii) the need to foster the company’s business … companies, and certain other financial institutions;
U.S. expatriates and certain former citizens or long-term residents of the United States
10-K
2023 FY
IMCR
Immunocore Holdings plc
28 Feb 24
Annual report
7:33am
awards.
We are dedicated to attracting and retaining the best possible talent. Our compensation program, including short- and long-term incentives … and benefits, is designed to allow us to attract and retain individuals whose skills are critical to our current and long-term success. Total
6-K
EX-99.3
6hwco459n3amc3atmt4
7 Nov 23
Current report (foreign)
7:09am
6-K
EX-99.2
38zkj
7 Nov 23
Current report (foreign)
7:09am
6-K
EX-99.4
6l582vs7 chd9w
10 Aug 23
Current report (foreign)
8:28am
6-K
EX-99.2
efdte23 5055iptxm
10 Aug 23
Current report (foreign)
8:28am
6-K
EX-99.2
gn0o5j
10 May 23
Current report (foreign)
7:27am
6-K
EX-99.1
pxfaq51e2py7potppq2
18 Apr 23
Immunocore presents new KIMMTRAK data confirming association between early ctDNA reduction and longer overall survival
4:15pm
6-K
EX-99.4
bex l8mq5o5
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-99.3
ytkt8
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
6-K
EX-99.2
0dqmv u8apaq1k8
9 Nov 22
Index to Unaudited Condensed Consolidated Interim Financial Statements
7:15am
424B7
ee4ftvzk
30 Sep 22
Prospectus with selling stockholder info
4:15pm
6-K
EX-1.1
p4yla9 lh09xevnvkzgj
9 Sep 22
Cautionary Note Regarding Forward Looking Statements
4:29pm
424B5
6wqnduod13f7
9 Sep 22
Prospectus supplement for primary offering
4:23pm
424B7
44kifag36gk4
5 May 22
Prospectus with selling stockholder info
12:00am
F-3ASR
2guiagev
4 Apr 22
Automatic shelf registration (foreign)
4:08pm